EGFR Mutations in Lung Cancer: How Early Treatment is Changing Everything! 💥 #oncologycare

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Updates in EGFR-Mutated Non-Small Cell Lung Cancer - Lung Cancer Key Developments OncPanel 2025-26

Remember cell signaling pathways and kinase cascades? Epidermal growth factor receptor (EGFR) is a member of the ErbB family of ligand-activated tyrosine kinase receptors. These play roles in the proliferation of various cells, such as fibroblasts as well as oncogenesis. Once EGFR binds to its ligand, EGF, this causes the receptor to dimerize and undergo autophosphorylation on multiple tyrosine residues. Then, the protein Shc binds and is quickly phosphorylated by EGFR on its tyrosine residue. P

Epidermal Growth Factor Receptors simplified

Afatinib inhibits EGFR Receptor activation

Introduction to EGFR inhibitors

EGFR Mutation For Lung Cancer | EGFR Inhibitors | Diagnosis & Symptoms Of EGFR-Positive Lung Cancer